Trial Profile
A retrospective trial evaluating the long-term efficacy, safety and prognostic factors of low dose triple therapy of gabapentin or pregabalin, amitriptyline, and non- steroidal anti-inflammatory drugs in patients with bladder pain syndrome/interstitial cystitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Amitriptyline (Primary) ; Gabapentin (Primary) ; Pregabalin (Primary)
- Indications Interstitial cystitis; Pain
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2016 New trial record
- 16 Sep 2016 Long-term treatment outcomes, recurrence, adverse effects, and prognostic factors results (n=113) presented at the 46th Annual Meeting of the International Continence Society.